Where Prostate Cancer Begins
/
Prostate cancer researchers studying genetic variations have pinpointed 45 genes associated with disease development and progression.
Read More
PROSTATE HEALTH
Turmeric, the Many-Faceted Cancer-Killer
/
What's orange, spicy, fights prostate cancer, and whitens your teeth?
Read MoreMathematics VS. Prostate Cancer
/
A mathematical model that uses four consecutive prostate-specific antigen (PSA) test results from a patient who had prostate cancer surgery can predict the time it might take for the disease to relapse.
Read MoreJamming Prostate Cancer's On & Off Switch
/
Aside from non-melanoma skin cancer, prostate cancer is the most common cancer among men in the U.S., according to the Centers for Disease Control and Prevention. It is also one of the leading causes of cancer death among men of all races.
Read MoreIs There A Blueprint For Prostate Cancer?
/
Cancer researchers have applied a comprehensive set of analytical tools to lethal cases of metastatic prostate cancer, yielding a detailed map of the complex networks of interactions among genes and proteins that enable prostate cancer cells to proliferate and evade treatment.
Read MoreCombating High Risk Prostate Cancer
/
Men with very high-risk prostate cancer, who are treated at hospitals with a high proportion of administered radical local treatment (radiotherapy or prostatectomy), only have half of the mortality risk of men who are treated at hospitals with the lowest proportion.
Read MorePatient-Specific Therapies for Prostate Cancer
/
Cancer researchers have developed a computational approach for analyzing patient-specific data to help doctors choose the most effective drugs for individual patients.
Read MoreBest diets to prevent prostate cancer
/
Most men like a plan of action and here is a dietary plan all men should embrace that could curtail their chance of developing prostate cancer.
Read MoreCan Prostate Cancer Be Suppressed?
/
Although it reads like European license plate number, a protein known as ZMYND8 has demonstrated its ability to block metastasis-linked genes in prostate cancer.
Read MoreIs There an Antibody for Prostate Cancer?
/
In the study published in the journal Oncotarget, 10 men with metastatic prostate cancer resistant to androgen deprivation therapy and the androgen receptor antagonist enzalutamide were treated with pembrolizumab, a monoclonal antibody that binds to the PD-1 receptor.
Read MoreWatchful Waiting & Prostate Cancer
/
Over 90 percent of prostate cancers are detected at a curable stage, with men more likely to die of other diseases than from this cancer.
Read MoreEarly Warning for Recurring Prostate Cancer
/
Changes in benign tissues next to prostate tumors may provide an early warning for patients at higher risk for biochemical recurrence after a radical prostatectomy.
Read More